|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Internal Medicine (Dr. Shen), En-Chu-Kong Hospital; and Department of Internal Medicine (Drs. Jerng, Yu, and Yang), National Taiwan University Hospital, Taipei, Taiwan.
Correspondence to: Jih-Shuin Jerng, MD, Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung Shan South Rd, 100 Taipei, Taiwan; e-mail: jsjerng{at}ha.mc.ntu edu.tw
| Abstract |
|---|
|
|
|---|
Design: Retrospective study.
Setting: A 16-bed medical ICU at a community hospital.
Patients and methods: We reviewed 53 patients with CWP and ARF requiring invasive MV in the ICU for the first time between August 1998 and March 2002.
Results: Of the 53 patients with CWP, 28 patients (53%) with PMF had their first ARF at a younger age than those without PMF (69.1 ± 7.9 years vs 74.8 ± 7.2 years, p = 0.008 [mean ± SD]). Pneumonia (49%) was the most common cause of ARF. The mean APACHE (acute physiology and chronic health evaluation) II score was 26.0 ± 9.9, and the mean ICU stay was 14.7 ± 16.1 days. Twenty-one patients (40%) were weaned successfully in the ICU, with mean ventilator time of 17.0 ± 25.1 days. The ICU and in-hospital mortality rates were 40% and 43%, respectively. The median survivals for all patients and the ICU survivors were 2.6 months and 14.3 months, respectively. Multivariate analysis showed the following risk (or protective) factors for the ICU mortality: PaCO2 > 45 mm Hg at the time of intubation (adjusted odds ratio [OR], 0.04; 95% confidence interval [CI], 0.003 to 0.44), PaO2/fraction of inspired oxygen ratio < 200 mm Hg at the time of intubation (OR, 8.78; 95% CI, 1.36 to 56.48), and APACHE II score
25 (OR, 11.99; 95% CI, 1.49 to 96.78). PMF was not associated with the ICU mortality (OR, 1.18; 95% CI, 0.20 to 7.10).
Conclusions: Radiographic PMF was not associated with the ICU mortality in patients with CWP and ARF receiving invasive MV in the ICU. Although a substantial proportion of them could be weaned from the ventilator and discharged from the hospital, their long-term prognosis was poor.
Key Words: acute respiratory failure coal workers pneumoconiosis mechanical ventilation
| Introduction |
|---|
|
|
|---|
The pattern and severity of respiratory impairment in coal workers pneumoconiosis (CWP) are related to the levels of coal mine dust exposure, geologic factors, exposure to other respiratory hazards, and immunologic response to dusts.16 17 18 Estimation of disease severity in CWP conventionally involves a combination of radiographic and lung function assessment.17 18 Radiographically, CWP is classified into two forms: simple and complicated, based on the absence or presence of progressive massive fibrosis (PMF).17 18 In patients with simple CWP, lung function is minimally impaired and life expectancy is similar to that of the general population.16 17 18 However, prominent obstructive and restrictive abnormalities have been noted in patients with complicated CWP, whose survival rates are reduced substantially.16 17 18 This does not imply that the outcome of patients with CWP and ARF would be worse in complicated CWP, because clinical observations have shown that considerable variations in the magnitude of pulmonary impairment exist in complicated CWP.19 Since there is a lack of outcome data on patients with CWP and ARF, we undertook this study to investigate this issue and the prognostic implications of PMF.
| Materials and Methods |
|---|
|
|
|---|
For each patient, we reviewed all available pertinent chest radiographs within 3 years before admission to the hospital. The chest radiographs obtained at the nearest time before intubations were selected for radiographic classification. The images were reinterpreted and compared with standard reference radiographs by two pulmonologists who did not know the patients clinical conditions. In case they disagreed, a consensus was made. The designation of radiographic profusion category was simplified as a three-level classification (1 = 0/-, 0/0, 0/1, 1/0, 1/1, 1/2; 2 = 2/1, 2/2, 2/3; 3 = 3/2, 3/3, 3/+). Small opacities in the parenchyma were classified by shape and size: p, q, or r for rounded opacities (diameter, < 1.5 mm, 1.5 to 3 mm, or > 3 mm, respectively) and s, t, or u for irregular opacities (of width, < 1.5 mm, 1.5 to 3 mm, or > 3 mm, respectively).20
Radiographic PMF was defined by the presence of one or more large opacities
1 cm in diameter, and was classified as A (for one or more such opacities but not exceeding a combined diameter of 5 cm), B (one or more larger opacities than A and whose combined area does not exceed the upper zone of the right lung), or C (larger than B).20
In cases with poor radiograph quality or a standing radiograph not available, only the presence of PMF was addressed. For small opacities, only the predominant types were recorded.
Data Collection and Definitions
The following clinical data were collected for each patient: age and sex; body mass index; baseline pulmonary functions obtained by body plethysmography (V6200 Autobox; SensorMedics; Yorba Linda, CA); smoking, mining and medical histories; clinical symptoms; ECG for cor pulmonale;4
APACHE (acute physiology and chronic health evaluation) II score; serum albumin and arterial blood gas (ABG) levels on ICU admission; causes of ARF; durations of invasive MV before hospital discharge and ICU stay; and outcome.
A positive smoking history was designated for either current or ex-smokers. Chronic respiratory symptoms were defined as chronic cough for > 3 months with or without dyspnea, and with or without long-term use of bronchodilators (> 3 months). Cor pulmonale was defined by at least one of the following three ECG criteria: presence of p pulmonale, right ventricular hypertrophy, or right-axis deviation.4
Definitions of various medical diseases were as follows: tuberculosis for those with documented or treated cases; diabetes mellitus for those with a fasting glucose level > 126 mg/dL, or a history of prior use of insulin or oral hypoglycemic agents; hypertension for those with documented history (systolic BP
140 mm Hg or diastolic BP
90 mm Hg on more than two clinic visits), with or without antihypertensive treatment; coronary artery diseases for those with a history of myocardial infarction or confirmed by coronary angiography. Pneumonia was defined as the presence of fever, new or aggravated productive cough, dyspnea, or leukocytosis (WBC count > 11,000/µL), and new pulmonary infiltrates on the chest radiograph. Acute exacerbation of chronic respiratory insufficiency was considered if isolated respiratory tract infection without new pulmonary infiltrates was diagnosed, or the cause of ARF could not be identified. Shock was defined as systolic BP < 90 mm Hg, which lasted for > 4 h or required vasopressor use.
Those who were readmitted to the ICU within 72 h after being discharged were considered to have the same ICU stay; otherwise, the ICU readmission was regarded as a hospital stay. All patients received MV with the Evita 2 ventilators (Drägerwerk; Aktiengesellschaft, Germany). Weaning failure was defined by the inability to maintain spontaneous breathing for > 72 h, or death within 72 h after extubation. For patients discharged alive from the hospital, the outcomes concerning survival and ventilator dependency were confirmed by follow-up telephone interviews and death certificates. For patients unable to be contacted, the latest dates of known follow-up during the study period were designated as the censor dates.
Statistics
Statistical analysis was performed with a computer program (SPSS for Windows, version 10.0; SPSS; Chicago, IL). Values were expressed as means ± SD. Comparisons between those with and without PMF and between ICU survivors and nonsurvivors were made using the Student t test, and
2 or Fisher exact test. The Pearsons product-moment correlation was used to assess the relationship between the two continuous variables. To investigate the prognostic factors, proportions of variables in the univariate analysis were compared with the
2 test after excluding variables with missing values. Multivariate analysis was performed with entering all the variables in the logistic regression model. To assess and present the potential confounding factors of the ICU mortality more clearly, both the crude and adjusted odds ratios (ORs) are calculated. A p value of < 0.05 was considered significant. A life table was computed using the Kaplan-Meier method.
| Results |
|---|
|
|
|---|
|
|
Twenty-one patients (40%), including 4 patients undergoing tracheostomy, were weaned successfully in the ICU with a ventilator time of 17.0 ± 25.1 days; all of them survived to hospital discharge. Tracheostomy was performed in 11 patients (21%) with a mean time of 21.6 ± 16.3 days after intubation; 9 of these patients survived to hospital discharge. Of the 11 patients who were not weaned during the ICU stay, 2 died in the hospital, 7 became ventilator dependent, and 2 were weaned eventually but were bedridden and required continuous oxygen support. Of the seven miners who survived but remained ventilator dependent, two were eventually weaned from ventilator (5 months and 7 months after discharge, respectively), one was still ventilator dependent 5 months after discharge, three died (1 month, 2 months, and 6 months after discharge, respectively), and one was unavailable for follow-up. The ICU and in-hospital mortality rates were 40% and 43%, respectively. The survival curve of the 53 patients is plotted in Figure 1 . Two patients were unavailable for follow-up after discharge. The median survivals for all patients and the 32 ICU survivors were 2.6 months and 14.3 months, respectively. There was no significant difference between the survival of the patients with simple CWP and those with complicated CWP (log-rank test, p = 0.772).
|
25 (OR, 11.99; 95% CI, 1.49 to 96.78). In a further comparison between patients with PaCO2 > 45 mm Hg (hypercapnia) and those with PaCO2 > 45 mm Hg at the time of intubation, patients with hypercapnia had a lower mean APACHE II score (22.7 ± 8.7 vs 28.4 ± 10.2, p = 0.035); but the correlation between PaCO2 and APACHE II score in all patients with CWP was poor (r = - 0.220, p = 0.114).
|
| Discussion |
|---|
|
|
|---|
The prognosis of patients with ARF requiring MV is different among various populations.1 2 3 4 5 6 7 8 9 10 11 12 13 14 In a review5 of unrestricted series of patients requiring MV for ARF, the 1-year mortality rates ranged from 60 to 84%. The worst outcomes were noted in patients with lung cancer and pulmonary fibrosis requiring invasive MV for ARF with hospital mortality rates of 91.3% and nearly 100%, respectively.11 12 13 14 In our series, the in-hospital (43%) and 1-year (approximately 60%) mortality rates were similar to those in COPD with ARF (20 to 50% and 44 to 66%, respectively, in studies since 1980).4 5 6 7 8 9 10
In patients with COPD and ARF, there have been many reported prognostic variables, including the following: (1) features reflecting physiologic reserve, such as premorbid level of activity, FEV1, serum albumin level, severity of dyspnea, and presence of cor pulmonale or left ventricular failure; (2) nature and severity of acute illness, such as causes of ARF, initial blood gas data, and APACHE II score; and (3) development of complications, especially nonpulmonary organ failure.4 7 10 Due to different selection criteria and study designs, the specific variables associated with mortality are not consistent in these reports; nevertheless, mortality often is related to the nature of the precipitating illness and the severity of underlying chronic respiratory disease.
In this study, we found three independent variables were associated with the ICU mortality: PaCO2 and PaO2/FIO2 ratio at the time of intubation, and APACHE II score. The influence of cor pulmonale on the ICU mortality was not present after adjusting for other variables, since its presence favors COPD or other illnesses resulting in chronic respiratory insufficiency, which may also result in hypercapnia, a major prognostic factor shown in this study. It is surprising that a higher PaCO2 level at the time of intubation was associated with a better ICU outcome. The role of the PaCO2 level on the outcome of patients with chronic respiratory diseases has been controversial.15 21 22 23 24 25 In COPD before long-term oxygen therapy, hypercapnia on room air was found to be a negative prognostic factor.21 In patients with chronic respiratory insufficiency (including chronic bronchitis, asthma, bronchiectasis, tuberculosis sequelae, kyphoscoliosis, pulmonary fibrosis, and pneumoconiosis, except neuromuscular disorders) requiring domiciliary oxygen therapy or MV, hypercapnia on room air has been found to be a positive prognostic factor15 22 23 24 ; however, some studies15 21 25 showed a contrary result. In severe COPD with acute exacerbation with or without invasive MV, premorbid hypercapnia was not associated with survival.4 8 Since we did not encounter premorbid levels of PaCO2 and the patient population we investigated was different, it is difficult to compare our data with previous studies in this aspect. Nevertheless, there are several possible reasons that may explain the better prognosis of hypercapnic patients with CWP in this study. First, the severity of acute illness in the hypercapnic patients was milder, since the mean APACHE II score was lower compared with those without hypercapnia. Second, an obstructive component of CWP might have played a role. Since most of the patients were smokers (76%), the prognostic analysis might be confounded by a greater proportion of COPD, which would account for the higher PaCO2 level, increased frequency of cor pulmonale, and increased frequency of acute exacerbation as the cause of ARF in the ICU survivors. By contrast, the lower PaO2/FIO2 ratio in those who died in the ICU might suggest a greater proportion of functionally significant interstitial disease in that group. Third, the blood gas was obtained at the time of intubation, and the stability may have influenced the result.
Since epidemiologic studies16 17 18 have shown that patients with complicated CWP tend to have prominent obstructive and restrictive ventilatory abnormalities and reduced survival rates, it is striking that the presence of PMF was not associated with the ICU outcome in this study. There are several possible explanations. First, a selection bias is likely. Patients with more severe category of complicated CWP and poorer lung function might be not intubated and aggressively treated, and the result would be biased toward indiscriminate between simple and complicated CWP. Second, the presence of a higher PaCO2 level, a protective factor in this study, was observed in patients with complicated CWP. Third, the magnitude of pulmonary impairment among patients with complicated CWP might vary considerably.19 It is well known that PMF is not always a homogeneous mass of fibrous tissue, but in many cases has a soft core with substantially reduced collagenous material, which may act only as little more than a space-occupying lesion without significant compensatory emphysema.19 Therefore some patients with CWP exhibiting dramatic radiologic changes might have little or no accompanying disablement.19
We are aware that there are other factors that might have adversely affected the findings of our study. First, analysis based on severity of pneumoconiosis and pre-existing lung disease might have been more informative, but this is not feasible because lung function data were not available on more than half of the study population. Besides, the available lung function might be biased toward higher values since only less severe patients could perform lung function tests. Second, the follow-up duration was relatively short; thus, the long-term prognosis might have been underestimated. Nevertheless, it is important to be aware that the presence of PMF, a poor radiologic appearance, is not a predictor of poor outcome in patients with CWP who are intubated for ARF, but the results need to be confirmed by further studies.
In conclusion, radiographic PMF was relatively common in patients with CWP and ARF receiving invasive MV in the ICU, but its presence was not associated with the ICU mortality. Although a substantial proportion could be successfully weaned from the ventilator and discharged from the hospital, the long-term prognosis was poor.
| Footnotes |
|---|
The work was performed in En-Chu-Kong Hospital, Taipei, Taiwan.
Received for publication April 7, 2003. Accepted for publication September 3, 2003.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |